A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy - Wikidata - wikimedia - TriplyDB

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

http://www.wikidata.org/entity/Q28256358

about

Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?miR-155 as a Biomarker in B-Cell Malignancies Next-generation prognostic assessment for diffuse large B-cell lymphoma How I treat HIV-associated lymphoma Treatment of diffuse large B cell lymphoma Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1 Diffuse large B-cell lymphoma: current strategies and future directions A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphoma Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma.Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype The significance of FOXP1 in diffuse large B-cell lymphoma.Examining racial differences in diffuse large B-cell lymphoma presentation and survival.Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma.CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy.InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type Clinicopathologic analysis of localized nasal/paranasal diffuse large B-cell lymphoma Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications MicroRNA profiling of primary cutaneous large B-cell lymphomas Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.Immunohistochemical algorithm alone is not enough for predicting the outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.

P2860

Q24597424-D219F3CA-12A1-4C5F-A2B3-2C66A1E19150 Q26746573-246848E6-9B8E-4475-A261-7B91FE045188 Q26796428-87907010-A7CA-405B-8A03-D99B01B76392 Q26821860-C515B4B8-963B-45AE-9D80-027916AFD8E4 Q27006062-75BEC19C-BB36-40D7-A3D2-1E4CC3ABBCBC Q27312570-BB163A1C-9285-4629-9061-A875892BDFBF Q27314782-ACFF37B5-D62C-4F4D-B770-1BD82956FCDF Q28239225-C7C9BDD5-893D-4063-88EC-3053278B985A Q28269136-3BFF63ED-7110-4220-8112-D0A8332A6F28 Q30485971-D70742D8-2FBB-43BB-8277-479BE845D26D Q33583294-E1F72A3E-BCC3-4D67-9830-5259EA0FF1BF Q33591789-110FF7B9-8351-451E-B6EE-4BB32C94BF95 Q33622342-3391E6CA-F051-4C18-8159-A7B287DC6A96 Q33700531-210CF03C-C50C-430E-A878-30D07F72060D Q33701845-26640D9C-E935-46B9-89AE-B22BF02EF21A Q33729711-D2BDC64C-323B-4874-AD4D-01EEF4D1C6D2 Q33846801-5D6E5551-65AA-4555-BEF6-DC9ABEAB293A Q34032232-C2DECEDE-D8AD-4A57-A879-AB6B1AC71C17 Q34047455-CEB00D24-A080-4718-AF14-82B2A5FC1027 Q34117972-CD3B5454-54C3-4D85-8360-29E2A57EA458 Q34120178-46DD68E8-E839-4901-92DF-DC5AB47DEADC Q34292361-E0B7C0E7-96D1-4F0C-BF9C-A244FA712554 Q34360414-38090032-B693-4BCD-B685-3226A3D67ABD Q34390837-AC7DC72A-FC74-4E4B-B4A3-BD9F15DA5C56 Q34479414-7310D66B-D0C7-4950-BEFD-22FC985286C7 Q34481343-94B82FDD-C78D-4F07-B147-CF07877D425C Q34534640-BD240FF4-391C-402A-97D6-49FF16B0B66D Q34612336-39738AB6-F112-4513-8172-7ACE85951EF9 Q34617849-CF18229D-D9B5-473A-BD7F-D20109A8CB1E Q34670913-9E18CA1C-4F69-487A-AA3E-60A27DC161C3 Q34679166-04F1A42E-E9EC-4754-8D13-3D5688536AA4 Q34695303-DFBAE16A-FA96-42A7-AB68-ABC1B7F40C24 Q34866311-76E0BEF1-462E-421D-9D10-547DA7FCA6B2 Q34882773-A2F37CF0-AE40-4549-97DC-7A0B271CBE39 Q35029409-C7C3EAD4-7269-45C9-A2E0-7E13617BDDCB Q35072776-05F79683-C3FE-4C31-818B-BD137E77B588 Q35080097-09C8EE3C-10A3-4DF9-8301-F6989390F0AE Q35145270-7FB74B5C-EBD5-41CF-B8DC-84F2EB3C6E44 Q35153794-A98B9D63-624B-4EC5-89F0-61BBFC798F24 Q35193836-5EC444BF-7939-4D53-9CDD-DB67A1FA5AC0

P2860

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

http://www.wikidata.org/entity/Q28256358

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@ast

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@en

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@nl

type

label

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@ast

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@en

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@nl

prefLabel

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@ast

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@en

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@nl

P1433

Q28256358-34625611-4AC7-4E9A-8862-9D861BEB8F0F

P1476

Q28256358-582F3EA0-26BB-4E59-997B-505F0D72AFE0

P2093

Q28256358-0B292AF4-3150-4265-9D53-263CAA57F8F3

Q28256358-194816DF-BF3C-4CF7-8E88-4E15760B6521

Q28256358-32EA0E08-6B82-483E-85BC-279F43FAD969

Q28256358-41825570-6952-4F1A-B181-B068EF917243

Q28256358-4C054C09-EB5A-4D68-A65F-0148F279C4D7

Q28256358-56133079-5CE2-4071-B345-C08DEEF25CA2

Q28256358-79ADEF29-DEF9-4D1A-A8AC-EFF2ED270D9E

Q28256358-87667A43-1F70-4691-AF8E-1A1218C6DE84

Q28256358-970441E9-819B-4913-9E39-B22677A92FB2

Q28256358-9FB428C8-9E76-457F-8F37-7F86C092D77D

P304

Q28256358-EF532DAC-A7F3-40FD-B350-572E402BF2AC

P31

Q28256358-48500463-AE4D-427C-9538-7AF2F5D1779C

P3181

Q28256358-67756CEE-CE5B-4BD6-A52C-4FC9AC2CE983

P356

Q28256358-D4533C10-33BF-4A99-9CA1-D575A6771DE0

P407

Q28256358-655A3231-8896-432A-AE63-55906174AC77

P433

Q28256358-A29FE38A-4FAB-4E93-BB7B-476DC1A1F1FF

P478

Q28256358-22052774-0299-4A7D-A8AB-779291F3D79A

P50

Q28256358-2619975A-DD6A-4FA2-B4B9-F52248E4F5D1

Q28256358-2DB13F8A-0E4C-4181-8752-D98280CBAA80

Q28256358-3A30EB33-85D2-403D-88D9-CE2F7877E5B2

Q28256358-421D7CFE-C4D0-4C19-841B-1658418538A8

Q28256358-6DC350B0-0795-4A9A-A632-60DC1B7F9335

Q28256358-73EDE7B0-D264-4575-A448-8BECA950C92C

Q28256358-802E68EE-D1FF-4221-A726-003F07FC5FE5

Q28256358-A6A3C372-2F07-4C08-B849-6C2EB897B6E7

Q28256358-D0274EA2-9827-424B-A885-FEB027692ED2

Q28256358-D2E5429D-4535-44BB-99F0-832501EFCC05

P577

Q28256358-6EC65A43-35E8-4EDE-BDA8-AD83B7AC5ADD

P698

Q28256358-035BD584-2C84-4D48-93B1-C4E2943D9988

P3181

P356

1078-0432.CCR-09-0113

P1433

Clinical Cancer Research

P1476

A new immunostain algorithm cl ...... ar subtypes with high accuracy

@en

P2093

Andreas Rosenwald

http://www.w3.org/2001/XMLSchema#string

Christine P Hans

http://www.w3.org/2001/XMLSchema#string

David L Jaye

http://www.w3.org/2001/XMLSchema#string

Elaine S Jaffe

http://www.w3.org/2001/XMLSchema#string

Georg Lenz

http://www.w3.org/2001/XMLSchema#string

Huimin Geng

http://www.w3.org/2001/XMLSchema#string

Javeed Iqbal

http://www.w3.org/2001/XMLSchema#string

Kai Fu

http://www.w3.org/2001/XMLSchema#string

Lisa M Rimsza

http://www.w3.org/2001/XMLSchema#string

Lynette M Smith

http://www.w3.org/2001/XMLSchema#string

P304

5494-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

796442

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-09-0113

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Alison H Banham

Miguel A. Piris

Randy D Gascoyne

Dennis D Weisenburger

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19706817

http://www.w3.org/2001/XMLSchema#string